F2G Ltd Announces Appointment Of New Chief Scientific Officer

January 12, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Manchester, England, 10th January 2007 - F2G Limited, specialists in research and development of new treatments for serious fungal infections in man, is pleased to announce the appointment of Dr Lloyd Payne as Chief Scientific Officer.

Twitter
LinkedIn
Facebook
Email
Print

People Europe